Sertaconazole Nitrate

硝酸舍他康唑

Report date: 2022/05/12 17:20:18
NME

Base Information

Drug NameSertaconazole Nitrate
Drug Alias Name塞他康唑Sertaconazolum舍他康唑sertaconazolDermoseptic +[14] 
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsDermatitis, AtopicTinea PedisCandidiasis, Vulvovaginal
Global Approved IndicationsTinea Pedis
Approved Indications in ChinaTinea Pedis
Original Approved Country/TerritoryMainland China
Original Approved Date2003/09/09
Country/TerritoryUnited StatesGermanyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesHainan Haishen Tongzhou Pharmaceutical Co Ltd
Inactive CompaniesSpirig Pharma Ltd
Active IndicationsTinea Pedis
Inactive IndicationsDermatitis, AtopicCandidiasis, Vulvovaginal

Other Information

ATC CodeD01AC14G01AF19
Related LinksWikipediaDrugBankKEGG